62 related articles for article (PubMed ID: 3469461)
21. Age-specific survival after Hodgkin's disease in a population-based cohort (United States).
Clarke CA; Glaser SL; Prehn AW
Cancer Causes Control; 2001 Nov; 12(9):803-12. PubMed ID: 11714108
[TBL] [Abstract][Full Text] [Related]
22. The National Cancer Data Base report on Hodgkin's disease for 1985-1989 and 1990-1994.
Kennedy BJ; Fremgen AM; Menck HR
Cancer; 1998 Sep; 83(5):1041-7. PubMed ID: 9731909
[TBL] [Abstract][Full Text] [Related]
23. Hodgkin's disease (H.D.)--a study of 111 cases seen at Gujarat Cancer & Research Institute, Ahmedabad.
Shah PM; Patel DD; Gavadia ML; Patel KH
J Assoc Physicians India; 1975 Aug; 23(8):519-22. PubMed ID: 1194225
[No Abstract] [Full Text] [Related]
24. Cancer epidemiology--Part VI. Hodgkin's disease.
Harberg J; Buchanan-Davidson DJ
Wis Med J; 1978 Dec; 77(12):25-6. PubMed ID: 735113
[No Abstract] [Full Text] [Related]
25. Hodgkin's disease in pediatric patients with naturally occurring immunodeficiency.
Robison LL; Stoker V; Frizzera G; Heinitz K; Meadows AT; Filipovich AH
Am J Pediatr Hematol Oncol; 1987; 9(2):189-92. PubMed ID: 3592132
[TBL] [Abstract][Full Text] [Related]
26. Space-time clustering of Hodgkin's Disease in parts of the UK, 1984-1993.
Gilman EA; McNally RJ; Cartwright RA
Leuk Lymphoma; 1999 Dec; 36(1-2):85-100. PubMed ID: 10613453
[TBL] [Abstract][Full Text] [Related]
27. Recent incidence and secular trends in Hodgkin's disease and its histologic subtypes.
Glaser SL
J Chronic Dis; 1986; 39(10):789-98. PubMed ID: 3760107
[TBL] [Abstract][Full Text] [Related]
28. Survival in Hodgkin's disease by stage and age.
Kennedy BJ; Loeb V; Peterson V; Donegan W; Natarajan N; Mettlin C
Med Pediatr Oncol; 1992; 20(2):100-4. PubMed ID: 1734213
[TBL] [Abstract][Full Text] [Related]
29. Hodgkin's disease survival by stage and age.
Kennedy BJ; Fremgen AM; Menck HR
J Am Geriatr Soc; 2000 Mar; 48(3):315-7. PubMed ID: 10733060
[TBL] [Abstract][Full Text] [Related]
30. Hodgkin disease survival in Europe and the U.S.: prognostic significance of morphologic groups.
Allemani C; Sant M; De Angelis R; Marcos-Gragera R; Coebergh JW;
Cancer; 2006 Jul; 107(2):352-60. PubMed ID: 16770772
[TBL] [Abstract][Full Text] [Related]
31. Increased survival in patients diagnosed with Hodgkin's disease in Tasmania, 1972-1992.
Strickland AH; Arthur GE; Matthews JP; Beresford JA; Lowenthal RM
Aust N Z J Med; 1998 Oct; 28(5):609-14. PubMed ID: 9847949
[TBL] [Abstract][Full Text] [Related]
32. Clustering of Hodgkin's disease in Israel: a case-control study.
Abramson JH; Goldblum N; Avitzur M; Pridan H; Sacks MI; Peritz E
Int J Epidemiol; 1980 Jun; 9(2):137-44. PubMed ID: 7409964
[TBL] [Abstract][Full Text] [Related]
33. Mortality in childhood Hodgkin's disease. An etiologic clue.
Miller RW
JAMA; 1966 Dec; 198(11):1216-7. PubMed ID: 5953506
[No Abstract] [Full Text] [Related]
34. Ongoing improvement in long-term survival of patients with Hodgkin disease at all ages and recent catch-up of older patients.
Brenner H; Gondos A; Pulte D
Blood; 2008 Mar; 111(6):2977-83. PubMed ID: 18096762
[TBL] [Abstract][Full Text] [Related]
35. Climate, socioeconomic status and Hodgkin's disease mortality in the United States.
DeLong ER; Maile MC; Grufferman S
J Chronic Dis; 1984; 37(3):209-13. PubMed ID: 6699125
[TBL] [Abstract][Full Text] [Related]
36. Carcinomas in children. Clinical and demographic characteristics.
Pratt CB; George SL; Green AA; Fields LA; Dodge RK
Cancer; 1988 Mar; 61(5):1046-50. PubMed ID: 3338049
[TBL] [Abstract][Full Text] [Related]
37. Methods of cancer case selection: implications for research.
Saftlas AF; Satariano WA; Swanson GM; Roi LD; Albert S
Am J Epidemiol; 1983 Dec; 118(6):852-6. PubMed ID: 6650486
[TBL] [Abstract][Full Text] [Related]
38. Retrospective Multicenter Real-Life Study on the First-Line Treatment of Classical Hodgkin Lymphoma in Argentina.
Mahuad C; Victoria O; Laura K; Enriqueta M; Fernando W; Hernán GR; Nancy C; Dana K; Marta Z; Gonzalo G; de Los Ángeles VRM; Florencia A; Erica RB; Susana C; Eugenia FM; Iliana P; Cecilia F; Anahí VB; Santiago C; Adriana V; Mariela G; Justina L; Claudia C; Manuela C; Luciana M; Cecilia CLM; Augusto M; Laura F; Maximiliano P; Marcela M; Silvana C
Clin Hematol Int; 2022 Jun; 4(1-2):44-51. PubMed ID: 35950206
[TBL] [Abstract][Full Text] [Related]
39. Impact of Provider Volume on Outcomes of Patients With Hodgkin Lymphoma.
Ireland C; Wiedower E; Mirza M; Crawley M; Tran A; Yaghmour G; Martin MG
World J Oncol; 2018 Apr; 9(2):46-49. PubMed ID: 29760832
[TBL] [Abstract][Full Text] [Related]
40. Improving outcomes in lung cancer: the value of the multidisciplinary health care team.
Denton E; Conron M
J Multidiscip Healthc; 2016; 9():137-44. PubMed ID: 27099511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
